Human epidermal growth factor receptor 2 (HER2) is an important indicator for molecular typing of breast cancer, and glycoantigen 19-9 (CA19-9) is used as an important indicator to judge the prognosis of pancreatic cancer2. The gene discussed is ERBB2; the disease is breast carcinoma.